- Home
- FRBA vs CMPS Comparison
FRBA vs CMPS Comparison
Compare FRBA & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRBA
- CMPS
- Stock Information
- Founded
- FRBA 2007
- CMPS 2020
- Country
- FRBA United States
- CMPS United Kingdom
- Employees
- FRBA N/A
- CMPS N/A
- Industry
- FRBA Major Banks
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- FRBA Finance
- CMPS Health Care
- Exchange
- FRBA Nasdaq
- CMPS Nasdaq
- Market Cap
- FRBA 369.7M
- CMPS 362.6M
- IPO Year
- FRBA N/A
- CMPS 2020
- Fundamental
- Price
- FRBA $14.80
- CMPS $4.41
- Analyst Decision
- FRBA Buy
- CMPS Strong Buy
- Analyst Count
- FRBA 1
- CMPS 7
- Target Price
- FRBA $17.00
- CMPS $30.67
- AVG Volume (30 Days)
- FRBA 44.3K
- CMPS 1.5M
- Earning Date
- FRBA 10-23-2024
- CMPS 10-31-2024
- Dividend Yield
- FRBA 1.62%
- CMPS N/A
- EPS Growth
- FRBA 54.36
- CMPS N/A
- EPS
- FRBA 1.60
- CMPS N/A
- Revenue
- FRBA $123,433,000.00
- CMPS N/A
- Revenue This Year
- FRBA N/A
- CMPS N/A
- Revenue Next Year
- FRBA $5.07
- CMPS N/A
- P/E Ratio
- FRBA $9.26
- CMPS N/A
- Revenue Growth
- FRBA 34.10
- CMPS N/A
- 52 Week Low
- FRBA $11.20
- CMPS $4.05
- 52 Week High
- FRBA $15.87
- CMPS $12.75
- Technical
- Relative Strength Index (RSI)
- FRBA 51.81
- CMPS 31.94
- Support Level
- FRBA $14.47
- CMPS $4.47
- Resistance Level
- FRBA $15.58
- CMPS $4.88
- Average True Range (ATR)
- FRBA 0.42
- CMPS 0.45
- MACD
- FRBA -0.00
- CMPS -0.03
- Stochastic Oscillator
- FRBA 51.53
- CMPS 11.89
About FRBA First Bank
First Bank is a full-service commercial bank, with an emphasis on providing personal and business financial services to individuals and small to mid-sized businesses. The Bank provides its customers with a variety of financial services targeting all segments of the retail and corporate market. Its Business Banking offers commercial deposit accounts, business loans, online banking, and cash management.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.